Category: Progress

Canadian Night at ASCO 2025

Join Us at ASCO 2025 – BCC’s Canadian Night The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the most influential cancer research conferences in the world,

Dr. Mita Manna Appointed Chair of REAL Canadian Breast Cancer Alliance

REAL Canadian Breast Cancer Alliance is pleased to announce the appointment of Dr. Mita Manna as the new Chair of the organization. Dr. Manna, a highly respected Hematologist and Medical

Minister of Health’s Decision to Pause Canadian Task Force on Preventive Health Care

FOR IMMEDIATE RELEASE March 4, 2025 Breast Cancer Canada Responds to Minister of Health’s Decision to Pause Canadian Task Force on Preventive Health Care A Defining Moment to Improve Breast

Meet the Researcher: Dr. Samir Fasih

Dr. Samir Fasih is a Clinical Research Fellow in the Department of Oncology at Western University and the London Health Sciences Centre. He is conducting BCC-funded breast cancer research under

Breast Cancer Canada’s Path for 2025: Prioritizing Early Detection, Timely Access, and Breakthrough Research

Toronto, ON, January 8, 2025 – Breast Cancer Canada is committed to its mission to advance breast cancer research, advocate for equitable care, and alleviate the burdens facing patients and

Year-End Milestones to Advance Breast Cancer Care Across Canada

Advancing Personalized Approaches: New Research Initiatives Announced Breast Cancer Canada, a national charity dedicated to advancing breast cancer research and care, is excited to announce several initiatives that underscore its

Diverse voices shape key issues in Breast Cancer Canada Progress Report:

Breast cancer rates are rising in younger populations, and when early detection can save lives, education is crucial to reduce mortality rates. By Angelica Bottaro Published Dec 19, 2024 Having

Rethinking Dosage Optimization in Breast Oncology

At the 2024 San Antonio Breast Cancer Symposium®, a dynamic workshop on Dose Optimization in Breast Medical Oncology shed light on the shift away from how researchers have traditionally determined

Results from the OlympiA Trial on Olaparib for High-Risk Breast Cancer Patients

Results from the OlympiA Trial on Olaparib for High-Risk Breast Cancer Patients Today we were a part of a pivotal moment in breast cancer research at SABCS 2024. The long-term

Immediate vs. Deferred Breast Surgery in Women Aged 70+

We’re reporting live from the San Antonio Breast Cancer Symposium (SABCS) 2024, where new research is shaping the future of breast cancer care. One of the highlights so far is

Sign Up, Know More